6-Bromo-4-[2-(8-hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl)-ethyl]-naphthalene-2-carboxylic acid ethyl ester

ID: ALA348608

PubChem CID: 10671524

Max Phase: Preclinical

Molecular Formula: C21H21BrN4O3

Molecular Weight: 457.33

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)c1cc(CCn2cnc3c2NC=NCC3O)c2cc(Br)ccc2c1

Standard InChI:  InChI=1S/C21H21BrN4O3/c1-2-29-21(28)15-7-13-3-4-16(22)9-17(13)14(8-15)5-6-26-12-25-19-18(27)10-23-11-24-20(19)26/h3-4,7-9,11-12,18,27H,2,5-6,10H2,1H3,(H,23,24)

Standard InChI Key:  LROMFLPKEXQPSI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
    1.8292   -2.1125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2667   -2.5250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0792   -1.5667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8000   -2.2125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2292   -3.1167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6750   -1.6292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4042   -2.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3667   -3.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3667   -2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9292   -2.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8875   -3.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2417   -2.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8917   -2.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4042   -3.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7417   -3.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1625   -3.2792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3250   -2.5292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8417   -3.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8417   -2.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9542   -1.6417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8792   -4.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8417   -4.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4625   -2.5542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9000   -1.7042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9500   -2.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3542   -4.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3167   -4.3417    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    6.4542   -3.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9792   -3.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  1  1  0
  4  2  1  0
  5  2  1  0
  6  3  2  0
  7 13  2  0
  8  9  2  0
  9 19  1  0
 10  7  1  0
 11  8  1  0
 12  1  1  0
 13  9  1  0
 14  7  1  0
 15  5  1  0
 16 25  1  0
 17  4  1  0
 18  8  1  0
 19 17  1  0
 20 10  2  0
 21 11  1  0
 22 18  2  0
 23 10  1  0
 24 12  1  0
 25 12  1  0
 26 22  1  0
 27 22  1  0
 28 23  1  0
 29 28  1  0
  6  4  1  0
 15 16  2  0
 14 11  2  0
 21 26  2  0
M  END

Associated Targets(Human)

AMPD3 Tchem AMP deaminase 3 (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ADA Adenosine deaminase (739 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 457.33Molecular Weight (Monoisotopic): 456.0797AlogP: 3.71#Rotatable Bonds: 5
Polar Surface Area: 88.74Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.06CX Basic pKa: 6.50CX LogP: 3.08CX LogD: 3.03
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.57Np Likeness Score: -0.24

References

1. Kasibhatla SR, Bookser BC, Xiao W, Erion MD..  (2001)  AMP deaminase inhibitors. 5. Design, synthesis, and SAR of a highly potent inhibitor series.,  44  (4): [PMID:11170651] [10.1021/jm000355t]

Source